Hypergonadotropic ovarian insufficiency in women of late reproductive age

• Autorzy: Khvoryk N. , Aliazaa H.A.
• Języki publikacji: EN

Abstrakty

EN

Background: At present, the increasing frequency of hypergonadotropic ovarian insufficiency in women of late reproductive periods is associated with various problems, which requires the development of new criteria and an integrated approach to solving these problems. Aim of the study: To investigate the causes, clinical manifestations and diagnostic criteria of hypergonadotropic ovarian insufficiency in women of late reproductive age. Material and methods: We examined 42 patients with clinical and laboratory criteria for hypergonadotropic ovarian failure. The causes and clinical manifestations of hypergonadotropism, as related to ovarian failure, in women of late reproductive age were revealed through this analysis. Results: Women aged 36–42 years that have had previous surgery on pelvic organs often undergo changes typical of hypergonadotropism. Certain clinical indicators such as lability of follicle-stimulating hormone (FSH) levels and other direct and indirect signs of decreased ovarian reserves allow practitioners to prescribe appropriate therapy on time. Timely diagnosis and an individualized approach can help prevent symptoms of hypoestrogenia and related complications. The results of this study show that early detection of a luteal out-of-phase (LOOP) event, along with a more detailed history was diagnosed in 16 (38.1%) of cases. Early detection allows more timely changes in diagnosis, may noted signs that can reflect both the normal state and pathology. Conclusions: Levels of Anti-Müllerian hormone, basal levels of FSH in two successive cycles, early detection of an LOOP-event and the use of ultrasound are significant factors that can help in the assessment of ovarian reserves.

• Wydawca: -
• Czasopismo: Medical Science Pulse
• Rocznik: 2020
• Tom: 14
• Numer: 1
• Opis fizyczny: p.10-14,ref.

Twórcy

autor

Khvoryk N.

• Grodno State Medical University, Grodno, Belarus

autor

Aliazaa H.A.

• Grodno State Medical University, Grodno, Belarus

Bibliografia

• 1. Fraison E, Crawford G, Casper G, Harris V, Ledger W. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online 2019; 39(3): 467–476.
• 2. Petrov YUA, Blesmanovich AE, Alekhina AG. Prezhdevremennaya ovarial’naya nedostatochnost’ (obzor literatury) [Premature ovarian failure]. Tavricheskij mediko-biologicheskij vestnik 2018; 2(21): 207–212. (In Russian).
• 3. Bricaire L, Laroche E, Bourcigaux N, Donadille B, ChristinMaitre S. Insuffisances ovarienes prematures. Presse Med 2013; 42(11): 1500–1507. (In French).
• 4. Sharif K, Watad A, Bridgewood C, Kanduc D, Amital H, Shoenfeld Y. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab 2019; 16: 2–13.
• 5. Hamoda H, British Menopause Society and Women’s Health Concern. The British Menopause Society and Women’s Health Concern recommendations on the management of women with premature ovarian insufficiency. Post Reprod Health 2017; 23(1): 22–35.
• 6. Candiani M, Ottolina J, Posadzka E, Ferrari S, Castellano L, Tandoi I, et al. Assessment of ovarian reserve after cystectomy versus ‘one-step’ laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial. Hum Reprod 2018; 33(12): 2205–2211.
• 7. Kalampokas T, Kamath M, Kalampokas E. AMH after laparoscopic surgery of the ovaries: a review. Gynecol Endocrinol 2013 May; 29(5): 408–411.
• 8. Gur’yev V, Kurakina V. Otsenka faktorov, opredelyayushchikh ovarial’nyy rezerv u zhenshchin s narushennoy reproduktivnoy funktsiyey. Zhurnal akusherstva i ginekologii 2012; 6: 76–81. (In Russian).
• 9. Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012 Apr; 19(4): 387–395.
• 10. Hwu Y, Wu F, Li S, Sun F, Lin M, Lee R. The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels. Reprod Biol Endocrinol 2011; 9: 80.
• 11. Hale G, Hughes C, Burger H, Robertson D, Fraser I. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition. Menopause 2009 Jan-Feb; 16(1): 50–59.
• 12. Sosnova EA. Embolizatsiya matochnykh arteriy pri miome matki u patsiyentok reproduktivnogo vozrasta i yee rol’ v formirovanii autoimmunnogo ooforita. Arkhiv akusherstva i ginekologii im. V.F. Snegireva 2016; 3(2): 81–87. (In Russian).
• 13. Adamyan LV, Kurilo LF, Shulyak IYU. Follikulogenez yaichnikov zhenshchin s nekotorymi formami endometrioza. Problemy reproduktsii 2009; 15(1): 78–85. (In Russian).

Identyfikatory

DOI

10.5604/01.3001.0013.9720